Massachusetts General Hospital, Department of Neurosurgery
Boston, United States
Gavin Dunn is a board-certified neurosurgeon who specializes in neurosurgical oncology. At MGH, he leads the Brain Tumor Immunology and Immunotherapy Program. His practice centers on the management of patients with primary and metastatic brain cancers as well as general neurosurgical conditions. He has a comprehensive background employing technological adjuncts such as awake surgery, cortical mapping, laser ablation, fluorescence-guided surgery, and stereotactic radiosurgery. He is a fellow and member of the American Association of Neurological Surgeons (AANS), member of the Congress of Neurological Surgeons (CNS) and Society for Immunotherapy of Cancer (SITC), and the Society for Neuro-Oncology (SNO). Gavin received his MD and PhD degrees at the Washington University School of Medicine and completed his neurosurgical training at the Massachusetts General Hospital. At MGH, his NIH-funded research program focuses on understanding the immune response to brain tumors and the fundamental basis of CNS immunobiology. His work on the Brain Tumor Immunity cycle involves preclinical models as well as translational work and clincal trial and protocol development. Gavin is also in the US Navy Reserves where he is the Specialty Leader for Neurosurgery.